These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4663247)

  • 21. [Smallpx vaccination].
    Just M
    Schweiz Med Wochenschr; 1968 Mar; 98(13):495-503. PubMed ID: 5700509
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of vaccination status on the clinical form and outcome of the disease in smallpox patients (author's transl)].
    Kecmanaovć M; Suvaković V
    MMW Munch Med Wochenschr; 1975 Jan; 117(3):87-92. PubMed ID: 803614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The eradication of smallpox in Shanghai, China, October 1950-July 1951.
    Hui X; Yutu J
    Bull World Health Organ; 1981; 59(6):913-7. PubMed ID: 6978198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-benefit analysis of the intensified campaign against smallpox in India.
    Ramaiah TJ
    NIHAE Bull; 1976; 9(3):169-203. PubMed ID: 829270
    [No Abstract]   [Full Text] [Related]  

  • 25. [Determination of the duration of post-vaccinal smallpox immunity by means of hemagglutination-inhibiting antibodies].
    Topciu V; Plavosin-Babusceac L; Csaky N; Reichrath S
    Arch Hyg Bakteriol; 1968 Dec; 152(5):422-6. PubMed ID: 5754319
    [No Abstract]   [Full Text] [Related]  

  • 26. Problem of persistence of facial pock marks among smallpox patients.
    Jezek Z; Basu RN; Arya ZS
    Indian J Public Health; 1978; 22(1):95-101. PubMed ID: 669769
    [No Abstract]   [Full Text] [Related]  

  • 27. [For and against smallpox vaccination. Epidemiological background and its significance for optimal vaccination time and optimal vaccination age].
    Ebel R; Hartmann J; Stickl H
    Fortschr Med; 1972 May; 90(14):533-6. PubMed ID: 4403686
    [No Abstract]   [Full Text] [Related]  

  • 28. Assessment of vaccination coverage, vaccination scar rates, and smallpox scarring in five areas of West Africa.
    Henderson RH; Davis H; Eddins DL; Foege WH
    Bull World Health Organ; 1973; 48(2):183-94. PubMed ID: 4541684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expected adverse events in a mass smallpox vaccination campaign.
    Kemper AR; Davis MM; Freed GL
    Eff Clin Pract; 2002; 5(2):84-90. PubMed ID: 11990216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The transmission pattern of smallpox in Eastern Mali.
    Fofana B; Imperato PJ; Nedvideck J
    Acta Trop; 1971; 28(2):175-9. PubMed ID: 4400552
    [No Abstract]   [Full Text] [Related]  

  • 31. [Smallpox vaccination].
    Ehrengut W
    Dtsch Med Wochenschr; 1973 Aug; 98(34):1585. PubMed ID: 4727399
    [No Abstract]   [Full Text] [Related]  

  • 32. [Smallpox: vaccination and incubation vaccination].
    Richter KH; Hoffmann F; Schwenen M
    Fortschr Med; 1972 Sep; 90(25):902-6. PubMed ID: 4642944
    [No Abstract]   [Full Text] [Related]  

  • 33. [Primary vaccination against smallpox after preliminary vaccination with the attenuated vaccinia virus strain MVA and the use of a new "vaccination stamp"].
    Stickl H; Hochstein-Mintzel V; Huber HC
    Munch Med Wochenschr; 1973 Aug; 115(35):1471-3. PubMed ID: 4740817
    [No Abstract]   [Full Text] [Related]  

  • 34. Smallpox eradication in West and Central Africa.
    Foege WH; Millar JD; Henderson DA
    Bull World Health Organ; 1975; 52(2):209-22. PubMed ID: 1083309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Introduction: vaccination against smallpox in the posteradication era.
    Chapman LE; Mootrey GT; Neff LJ
    Clin Infect Dis; 2008 Mar; 46 Suppl 3():S153-6. PubMed ID: 18284354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Duration of vaccination immunity to smallpox (epidemiological observation in Southeast Asia)].
    Vishniakov VE
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1973; 42():163-8. PubMed ID: 4808380
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pro and con smallpox vaccination. 2. Optimal vaccination time and optimal vaccination age].
    Ebel R; Hartmann J; Stickl H
    Fortschr Med; 1972 May; 90(15):578-83 concl. PubMed ID: 4405224
    [No Abstract]   [Full Text] [Related]  

  • 38. Complications of smallpox vaccination, 1968. Results of a statewide survey in Alaska.
    Clark PS; Lane JM
    Calif Med; 1971 Sep; 115(3):7-10. PubMed ID: 5094595
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The effectiveness of smallpox vaccination].
    Richter KH; Hoffmann F; Schwenen M
    Munch Med Wochenschr; 1972 Sep; 114(35):1496-502. PubMed ID: 4677977
    [No Abstract]   [Full Text] [Related]  

  • 40. [Effect of the initial level of immunity and allergy on the results of primary and repeated immunizations aagainst smallpox].
    Sokhin AA; Lebedinskii AP; Frolov AK; Frolov VK
    Vopr Okhr Materin Det; 1976 Dec; 21(12):29-34. PubMed ID: 1027262
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.